<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;fc=20230708114047&amp;ff=20250101051114&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;fc=20230708114047&amp;ff=20250101051114&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 01 Jan 2025 10:11:15 +0000</lastbuilddate>
<pubDate>Fri, 27 Dec 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Venous Endothelial Cell Transcriptomic Profiling Implicates METAP1 in Preeclampsia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39727051/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In a cohort of early postpartum individuals, we observed greater METAP1 expression in venous ECs of women with preeclampsia versus normotensive delivery. Mendelian randomization supported a causal relationship between greater vascular METAP1 expression and higher preeclampsia risk, and functional experiments demonstrated antiangiogenic and proinflammatory effects of METAP1 in human ECs consistent with alterations observed in preeclampsia. Ex vivo EC transcriptomics can identify...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Dec 27. doi: 10.1161/CIRCRESAHA.124.324606. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Preeclampsia is a hypertensive disorder of pregnancy characterized by systemic endothelial dysfunction. The pathophysiology of preeclampsia remains incompletely understood. This study used human venous endothelial cell (EC) transcriptional profiling to investigate potential novel mechanisms underlying EC dysfunction in preeclampsia.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Venous ECs were isolated from postpartum patients with severe preeclampsia and those with normotensive pregnancy using a J wire-based technique in the antecubital vein followed by CD144 magnetic bead isolation. Venous EC transcriptomes were compared between preeclamptic and normotensive individuals. Differentially expressed genes were carried forward for genetic validation using expression quantitative trait loci from the Genotype-Tissue Expression project as exposures for vascular-specific Mendelian randomization. Functional validation of the top candidate was performed in human umbilical vein ECs using gain- and loss-of-function genetic approaches.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Seventeen individuals with preeclampsia and 7 normotensive controls were included. Pairwise analysis yielded 14 protein-coding genes nominally differentially expressed in participants with preeclampsia. Mendelian randomization revealed a significant association between higher genetically predicted <i>METAP1</i> (methionyl aminopeptidase 1) expression in aortic and tibial arterial tissues and greater risk of preeclampsia. <i>METAP1</i> overexpression in human umbilical vein ECs decreased angiogenesis, with a 66% decrease in tube formation (<i>P</i>=7.9×10<sup>-3</sup>) and 72% decrease in cell proliferation (<i>P</i>=2.9×10<sup>-2</sup>). Furthermore, <i>METAP1</i> overexpression decreased <i>VEGFA</i> expression and increased expression of multiple preeclampsia-related genes, for example, <i>FLT1</i>, <i>INHBA</i>, and <i>IL1B</i>. Conversely, <i>METAP1</i> knockdown produced opposite effects on tube formation, cell proliferation, and inflammation-related gene expression.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In a cohort of early postpartum individuals, we observed greater <i>METAP1</i> expression in venous ECs of women with preeclampsia versus normotensive delivery. Mendelian randomization supported a causal relationship between greater vascular <i>METAP1</i> expression and higher preeclampsia risk, and functional experiments demonstrated antiangiogenic and proinflammatory effects of METAP1 in human ECs consistent with alterations observed in preeclampsia. Ex vivo EC transcriptomics can identify novel mechanisms underlying preeclampsia pathophysiology, with implications for prevention and treatment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39727051/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39727051</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324606>10.1161/CIRCRESAHA.124.324606</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39727051</guid>
<pubDate>Fri, 27 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Maria A Pabon</dc:creator>
<dc:creator>Robert M Weisbrod</dc:creator>
<dc:creator>Claire Castro</dc:creator>
<dc:creator>Haobo Li</dc:creator>
<dc:creator>Peng Xia</dc:creator>
<dc:creator>Jiayi Kang</dc:creator>
<dc:creator>Maddalena Ardissino</dc:creator>
<dc:creator>Katherine E Economy</dc:creator>
<dc:creator>Zihui Yang</dc:creator>
<dc:creator>Yanxi Shi</dc:creator>
<dc:creator>Eunice Kim</dc:creator>
<dc:creator>Anna Perillo</dc:creator>
<dc:creator>Leanne Barrett</dc:creator>
<dc:creator>Jenifer M Brown</dc:creator>
<dc:creator>Sanjay Divakaran</dc:creator>
<dc:creator>Murat Cetinbas</dc:creator>
<dc:creator>Ruslan I Sadreyev</dc:creator>
<dc:creator>Antonio de Marvao</dc:creator>
<dc:creator>Malissa J Wood</dc:creator>
<dc:creator>Nandita S Scott</dc:creator>
<dc:creator>Emily S Lau</dc:creator>
<dc:creator>Jennifer E Ho</dc:creator>
<dc:creator>Marcelo F Di Carli</dc:creator>
<dc:creator>Jason D Roh</dc:creator>
<dc:creator>Naomi M Hamburg</dc:creator>
<dc:creator>Michael C Honigberg</dc:creator>
<dc:date>2024-12-27</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Venous Endothelial Cell Transcriptomic Profiling Implicates METAP1 in Preeclampsia</dc:title>
<dc:identifier>pmid:39727051</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324606</dc:identifier>
</item>
<item>
<title>Spotlight on YAP: Unlocking New Insights to Overcome the Barriers to Heart Regeneration</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39723984/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>This editorial refers to “Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration” by Liu et al. and “YAP Overcomes Mechanical Barriers to Induce Mitotic Rounding and Adult Cardiomyocyte Division” by Morikawa et al.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 7;151(1):94-97. doi: 10.1161/CIRCULATIONAHA.124.072263. Epub 2024 Dec 26.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This editorial refers to “Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration” by Liu <i>et al</i>. and “YAP Overcomes Mechanical Barriers to Induce Mitotic Rounding and Adult Cardiomyocyte Division” by Morikawa <i>et al.</i></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39723984/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39723984</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11673915/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">PMC11673915</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072263>10.1161/CIRCULATIONAHA.124.072263</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39723984</guid>
<pubDate>Thu, 26 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Nivedhitha Velayutham</dc:creator>
<dc:creator>Richard T Lee</dc:creator>
<dc:date>2024-12-26</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Spotlight on YAP: Unlocking New Insights to Overcome the Barriers to Heart Regeneration</dc:title>
<dc:identifier>pmid:39723984</dc:identifier>
<dc:identifier>pmc:PMC11673915</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072263</dc:identifier>
</item>
<item>
<title>40th Anniversary of the TIMI Study Group</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39723982/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 7;151(1):4-7. doi: 10.1161/CIRCULATIONAHA.124.071210. Epub 2024 Dec 26.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39723982/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39723982</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071210>10.1161/CIRCULATIONAHA.124.071210</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39723982</guid>
<pubDate>Thu, 26 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Marc S Sabatine</dc:creator>
<dc:creator>Eugene Braunwald</dc:creator>
<dc:date>2024-12-26</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>40th Anniversary of the TIMI Study Group</dc:title>
<dc:identifier>pmid:39723982</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071210</dc:identifier>
</item>
<item>
<title>What Is the Mechanism of Atrial Fibrillation Initiation?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39723981/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 7;151(1):120-122. doi: 10.1161/CIRCULATIONAHA.124.072920. Epub 2024 Dec 26.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39723981/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39723981</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072920>10.1161/CIRCULATIONAHA.124.072920</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39723981</guid>
<pubDate>Thu, 26 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Gurukripa N Kowlgi</dc:creator>
<dc:creator>Samuel J Asirvatham</dc:creator>
<dc:creator>Konstantinos C Siontis</dc:creator>
<dc:date>2024-12-26</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>What Is the Mechanism of Atrial Fibrillation Initiation?</dc:title>
<dc:identifier>pmid:39723981</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072920</dc:identifier>
</item>
<item>
<title>Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39723980/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>There is a new awareness of the widespread nature of metabolic dysfunction-associated steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This has catalyzed collaboration between cardiologists, hepatologists, endocrinologists, and the wider multidisciplinary team to address the need for earlier identification of those with MASLD who are at increased risk for CVD. The overlap in the pathophysiologic processes and parallel prevalence of CVD, metabolic syndrome, and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 7;151(1):98-119. doi: 10.1161/CIRCULATIONAHA.124.070535. Epub 2024 Dec 26.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">There is a new awareness of the widespread nature of metabolic dysfunction-associated steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This has catalyzed collaboration between cardiologists, hepatologists, endocrinologists, and the wider multidisciplinary team to address the need for earlier identification of those with MASLD who are at increased risk for CVD. The overlap in the pathophysiologic processes and parallel prevalence of CVD, metabolic syndrome, and MASLD highlight the multisystem consequences of poor cardiovascular-liver-metabolic health. Metabolic dysfunction and associated insulin resistance, together with the predilection for ectopic fat deposition in the liver and surrounding tissues, are associated with elevated risk of endothelial dysfunction, systemic inflammatory response, and ectopic fat deposition in the epicardium. This complex pathophysiology can accelerate atherogenic dyslipidemia, atherogenesis, diastolic dysfunction, valvular calcification, and cardiac arrhythmias. Despite the mounting evidence of mechanistic pathways underpinning MASLD and CVD, current recommendations have not clearly focused upon MASLD as a risk factor or target for intervention in CVD. We have brought together a diverse range of international experts committed to promoting cardiovascular-liver-metabolic health and related outcomes across the globe. The overarching goal of this document is to offer a construct for clinicians in the cardiovascular field with regards to (1) diagnosis and screening of MASLD through the use of noninvasive serum and imaging tests; (2) screening for CVD in all individuals with MASLD regardless of established atherosclerotic risk factors; and (3) the approach to management of MASLD with respect to prevention of CVD through lifestyle, as well as pharmacologic and surgical strategies. To achieve this, the modified Delphi method was applied and a series of evidence-based quality standard recommendations have been identified.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39723980/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39723980</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070535>10.1161/CIRCULATIONAHA.124.070535</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39723980</guid>
<pubDate>Thu, 26 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Nicholas W S Chew</dc:creator>
<dc:creator>Anurag Mehta</dc:creator>
<dc:creator>Rachel Sze Jen Goh</dc:creator>
<dc:creator>Audrey Zhang</dc:creator>
<dc:creator>Yiming Chen</dc:creator>
<dc:creator>Bryan Chong</dc:creator>
<dc:creator>Han Shi Jocelyn Chew</dc:creator>
<dc:creator>Asim Shabbir</dc:creator>
<dc:creator>Adrian Brown</dc:creator>
<dc:creator>Georgios K Dimitriadis</dc:creator>
<dc:creator>Daniel Q Huang</dc:creator>
<dc:creator>Roger Foo</dc:creator>
<dc:creator>Carel W le Roux</dc:creator>
<dc:creator>Gemma A Figtree</dc:creator>
<dc:creator>Marat Fudim</dc:creator>
<dc:creator>Ambarish Pandey</dc:creator>
<dc:creator>Mamas A Mamas</dc:creator>
<dc:creator>Derek J Hausenloy</dc:creator>
<dc:creator>A Mark Richards</dc:creator>
<dc:creator>Stephen J Nicholls</dc:creator>
<dc:creator>Mark Y Chan</dc:creator>
<dc:creator>Mark D Muthiah</dc:creator>
<dc:creator>Arun Sanyal</dc:creator>
<dc:creator>Laurence S Sperling</dc:creator>
<dc:date>2024-12-26</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach</dc:title>
<dc:identifier>pmid:39723980</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070535</dc:identifier>
</item>
<item>
<title>Geographic Disparities in Availability of Hospital-Based Cardiac Services Across the United States</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39723979/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 7;151(1):123-124. doi: 10.1161/CIRCULATIONAHA.124.071778. Epub 2024 Dec 26.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39723979/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39723979</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071778>10.1161/CIRCULATIONAHA.124.071778</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39723979</guid>
<pubDate>Thu, 26 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Gabriel A Benavidez</dc:creator>
<dc:creator>Shanikque Blackwell</dc:creator>
<dc:creator>Peiyin Hung</dc:creator>
<dc:creator>Elizabeth Crouch</dc:creator>
<dc:date>2024-12-26</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Geographic Disparities in Availability of Hospital-Based Cardiac Services Across the United States</dc:title>
<dc:identifier>pmid:39723979</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071778</dc:identifier>
</item>
<item>
<title>Squeeze pumping of lipids and insecticides by ABCH transporter</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39721587/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>ATP-binding cassette (ABC) transporter subfamily H is only identified in arthropods and zebrafish. It transports lipids and is related to insecticide resistance. However, the precise mechanisms of its functions remain elusive. Here, we report cryoelectron microscopy (cryo-EM) structures of an ABCH from Tribolium castaneum, a worldwide pest of stored grains, in complex with an HEK293 cell-ceramide lipid, a fluorescent-labeled ceramide, a carbamate insecticide, and a maltose detergent inhibitor....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 18:S0092-8674(24)01375-8. doi: 10.1016/j.cell.2024.11.033. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">ATP-binding cassette (ABC) transporter subfamily H is only identified in arthropods and zebrafish. It transports lipids and is related to insecticide resistance. However, the precise mechanisms of its functions remain elusive. Here, we report cryoelectron microscopy (cryo-EM) structures of an ABCH from Tribolium castaneum, a worldwide pest of stored grains, in complex with an HEK293 cell-ceramide lipid, a fluorescent-labeled ceramide, a carbamate insecticide, and a maltose detergent inhibitor. We revealed a narrow, long, and arched substrate-binding tunnel in the transmembrane domains of the transporter dimer with two arginine-gated cytoplasmic entries for the binding and transport of lipids or insecticides. A pair of glutamines above the tunnel acts as a gate for directing substrate to be extruded via a vent-like hydrophilic exit to the extracellular side of the membrane upon ATP binding. Our structures and biochemical data provide mechanistic understanding of lipid transport, insecticide detoxification, and the inhibition of transporter activity by branched maltose detergents.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39721587/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39721587</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.033>10.1016/j.cell.2024.11.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39721587</guid>
<pubDate>Wed, 25 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Jinli Chen</dc:creator>
<dc:creator>Yanwei Duan</dc:creator>
<dc:creator>Yuanyuan Zhou</dc:creator>
<dc:creator>Qing Yang</dc:creator>
<dc:date>2024-12-25</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Squeeze pumping of lipids and insecticides by ABCH transporter</dc:title>
<dc:identifier>pmid:39721587</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.033</dc:identifier>
</item>
<item>
<title>Perception of a pathogenic signature initiates intergenerational protection</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39721586/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>Transmission of immune responses from one generation to the next represents a powerful adaptive mechanism to protect an organism's descendants. Parental infection by the natural C. elegans pathogen Pseudomonas vranovensis induces a protective response in progeny, but the bacterial cues and intergenerational signal driving this response were previously unknown. Here, we find that animals activate a protective stress response program upon exposure to P. vranovensis-derived cyanide and that a...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 24:S0092-8674(24)01342-4. doi: 10.1016/j.cell.2024.11.026. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Transmission of immune responses from one generation to the next represents a powerful adaptive mechanism to protect an organism's descendants. Parental infection by the natural C. elegans pathogen Pseudomonas vranovensis induces a protective response in progeny, but the bacterial cues and intergenerational signal driving this response were previously unknown. Here, we find that animals activate a protective stress response program upon exposure to P. vranovensis-derived cyanide and that a metabolic byproduct of cyanide detoxification, β-cyanoalanine, acts as an intergenerational signal to protect progeny from infection. Remarkably, this mechanism does not require direct parental infection; rather, exposure to pathogen-derived volatiles is sufficient to enhance the survival of the next generation, indicating that parental surveillance of environmental cues can activate a protective intergenerational response. Therefore, the mere perception of a pathogen-derived toxin, in this case cyanide, can protect an animal's progeny from future pathogenic challenges.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39721586/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39721586</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.026>10.1016/j.cell.2024.11.026</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39721586</guid>
<pubDate>Wed, 25 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Corinne L Pender</dc:creator>
<dc:creator>Julian G Dishart</dc:creator>
<dc:creator>Holly K Gildea</dc:creator>
<dc:creator>Kelsie M Nauta</dc:creator>
<dc:creator>Emily M Page</dc:creator>
<dc:creator>Talha F Siddiqi</dc:creator>
<dc:creator>Shannon S Cheung</dc:creator>
<dc:creator>Larry Joe</dc:creator>
<dc:creator>Nicholas O Burton</dc:creator>
<dc:creator>Andrew Dillin</dc:creator>
<dc:date>2024-12-25</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Perception of a pathogenic signature initiates intergenerational protection</dc:title>
<dc:identifier>pmid:39721586</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.026</dc:identifier>
</item>
<item>
<title>Takotsubo syndrome during percutaneous coronary intervention: the role of myocardial ischaemia and microvascular dysfunction in pathophysiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39718258/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 24:ehae902. doi: 10.1093/eurheartj/ehae902. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39718258/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39718258</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae902>10.1093/eurheartj/ehae902</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39718258</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Taiji Okada</dc:creator>
<dc:creator>Osamu Kurihara</dc:creator>
<dc:creator>Masamichi Takano</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Takotsubo syndrome during percutaneous coronary intervention: the role of myocardial ischaemia and microvascular dysfunction in pathophysiology</dc:title>
<dc:identifier>pmid:39718258</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae902</dc:identifier>
</item>
<item>
<title>Left ventriculo-atrial fistula following catheter ablation for Wolff-Parkinson-White syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39718255/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 24:ehae901. doi: 10.1093/eurheartj/ehae901. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39718255/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39718255</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae901>10.1093/eurheartj/ehae901</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39718255</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Zhen-Gang Zhao</dc:creator>
<dc:creator>Fei Chen</dc:creator>
<dc:creator>Yuan Feng</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Left ventriculo-atrial fistula following catheter ablation for Wolff-Parkinson-White syndrome</dc:title>
<dc:identifier>pmid:39718255</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae901</dc:identifier>
</item>
<item>
<title>Arterial conduits for coronary bypass grafting: the set-point concept</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39718243/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>Endothelial cells control the vascular tone of arterial grafts used for coronary artery bypass surgery and react to changes in local shear stress. The vascular adaptations induced by endothelial cell activation affect the outcome of surgical grafts and can be predicted based on the set-point theory. In this Hypothesis piece, it is proposed that the set-point concept should inform surgical decision making for coronary artery bypass surgery.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 24:ehae908. doi: 10.1093/eurheartj/ehae908. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Endothelial cells control the vascular tone of arterial grafts used for coronary artery bypass surgery and react to changes in local shear stress. The vascular adaptations induced by endothelial cell activation affect the outcome of surgical grafts and can be predicted based on the set-point theory. In this Hypothesis piece, it is proposed that the set-point concept should inform surgical decision making for coronary artery bypass surgery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39718243/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39718243</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae908>10.1093/eurheartj/ehae908</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39718243</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Antonio M Calafiore</dc:creator>
<dc:creator>Sotirios Prapas</dc:creator>
<dc:creator>Mario Gaudino</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Arterial conduits for coronary bypass grafting: the set-point concept</dc:title>
<dc:identifier>pmid:39718243</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae908</dc:identifier>
</item>
<item>
<title>Collagen Pyridinoline Cross-Links Are Absent in Reversible Myocardial Fibrosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39717913/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Dec 24. doi: 10.1161/CIRCRESAHA.124.325406. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39717913/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39717913</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325406>10.1161/CIRCRESAHA.124.325406</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39717913</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Eman Akam-Baxter</dc:creator>
<dc:creator>Sterling J Ridley</dc:creator>
<dc:creator>Brianna F Moon</dc:creator>
<dc:creator>Peter Caravan</dc:creator>
<dc:creator>David E Sosnovik</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Collagen Pyridinoline Cross-Links Are Absent in Reversible Myocardial Fibrosis</dc:title>
<dc:identifier>pmid:39717913</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325406</dc:identifier>
</item>
<item>
<title>Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39716283/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>Atrial fibrillation (AF) has become the pre-dominant arrhythmia worldwide and is associated with high morbidity and mortality. Its pathogenesis is intricately linked to the deleterious impact of cardiovascular risk factors, emphasizing the pivotal imperative for early detection and mitigation strategies targeting these factors for the prevention of primary AF. While traditional risk factors are well recognized, an increasing number of novel risk factors have been identified in recent decades....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 24:ehae887. doi: 10.1093/eurheartj/ehae887. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Atrial fibrillation (AF) has become the pre-dominant arrhythmia worldwide and is associated with high morbidity and mortality. Its pathogenesis is intricately linked to the deleterious impact of cardiovascular risk factors, emphasizing the pivotal imperative for early detection and mitigation strategies targeting these factors for the prevention of primary AF. While traditional risk factors are well recognized, an increasing number of novel risk factors have been identified in recent decades. This review explores the emerging non-traditional risk factors for the primary prevention of AF, including unhealthy lifestyle factors in current society (sleep, night shift work, and diet), biomarkers (gut microbiota, hyperuricaemia, and homocysteine), adverse conditions or diseases (depression, epilepsy, clonal haematopoiesis of indeterminate potential, infections, and asthma), and environmental factors (acoustic pollution and other environmental factors). Unlike traditional risk factors, individuals have limited control over many of these non-traditional risk factors, posing challenges to conventional prevention strategies. The purpose of this review is to outline the current evidence on the associations of non-traditional risk factors with new-onset AF and the potential mechanisms related to these risk factors. Furthermore, this review aims to explore potential interventions targeting these risk factors at both the individual and societal levels to mitigate the growing burden of AF, suggesting guideline updates for primary AF prevention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39716283/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39716283</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae887>10.1093/eurheartj/ehae887</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39716283</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Yingli Lu</dc:creator>
<dc:creator>Ying Sun</dc:creator>
<dc:creator>Lingli Cai</dc:creator>
<dc:creator>Bowei Yu</dc:creator>
<dc:creator>Yuying Wang</dc:creator>
<dc:creator>Xiao Tan</dc:creator>
<dc:creator>Heng Wan</dc:creator>
<dc:creator>Dachun Xu</dc:creator>
<dc:creator>Junfeng Zhang</dc:creator>
<dc:creator>Lu Qi</dc:creator>
<dc:creator>Prashanthan Sanders</dc:creator>
<dc:creator>Ningjian Wang</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies</dc:title>
<dc:identifier>pmid:39716283</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae887</dc:identifier>
</item>
<item>
<title>Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A Review</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714903/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: Although commercially available in numerous countries now for more than a decade, DCB only recently obtained US Food and Drug Administration approval for the treatment of coronary ISR. Moreover, preliminary results from newer generation devices tested in different clinical scenarios have raised the interest of the international community. Accordingly, an up-to-date review is timely particularly with the anticipated wave of research on the matter. Herein, this review...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Dec 23. doi: 10.1001/jamacardio.2024.4244. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Drug-coated balloon (DCB) angioplasty has emerged as an alternative to drug-eluting stent (DES) implantation for percutaneous coronary intervention (PCI) in patients with coronary in-stent restenosis (ISR) as well as de novo coronary artery disease.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBSERVATIONS: DCBs are balloons coated with antiproliferative agents and excipients, whose aim is to foster favorable vessel healing after appropriate lesion preparation. By providing homogeneous antiproliferative drug delivery in the absence of permanent foreign body implantation, DCBs offer multiple advantages over DES, including preservation of vessel anatomy and function and positive vessel remodeling. As such, DCBs have become appealing for treatment of ISR, small-vessel disease, long lesions, simplification of bifurcation procedures, and treatment of diffuse distal disease after recanalization of chronic total occlusions. In addition, patients with high bleeding risk, diabetes, and acute coronary syndrome might also stand to benefit from DCB angioplasty.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: Although commercially available in numerous countries now for more than a decade, DCB only recently obtained US Food and Drug Administration approval for the treatment of coronary ISR. Moreover, preliminary results from newer generation devices tested in different clinical scenarios have raised the interest of the international community. Accordingly, an up-to-date review is timely particularly with the anticipated wave of research on the matter. Herein, this review encompasses DCB technologies, their worldwide usage, details on relevant indications, and key procedural aspects of DCB angioplasty.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714903/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39714903</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.4244>10.1001/jamacardio.2024.4244</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714903</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Anton Camaj</dc:creator>
<dc:creator>Pier Pasquale Leone</dc:creator>
<dc:creator>Antonio Colombo</dc:creator>
<dc:creator>Manish Vinayak</dc:creator>
<dc:creator>Gregg W Stone</dc:creator>
<dc:creator>Roxana Mehran</dc:creator>
<dc:creator>George Dangas</dc:creator>
<dc:creator>Annapoorna Kini</dc:creator>
<dc:creator>Samin K Sharma</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A Review</dc:title>
<dc:identifier>pmid:39714903</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.4244</dc:identifier>
</item>
<item>
<title>Intravascular Sympathetic Stimulation to Facilitate Catheter Ablation of Premature Ventricular Complexes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714902/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: These findings suggest that intravascular sympathetic stimulation via the VV can be used to safely provoke PVCs during catheter ablation.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Dec 23. doi: 10.1001/jamacardio.2024.4447. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Infrequent intraprocedural premature ventricular complexes (PVCs) limit the efficacy of catheter ablation. Intravascular stimulation of sympathetic nerves via vertebral veins (VVs) has been used to activate cardiac sympathetic tone and may promote PVCs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To characterize the ability of direct electrical sympathetic stimulation via VVs to induce PVCs at the time of catheter ablation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This prospective case series involved adult patients undergoing catheter ablation of PVCs, with rare or absent PVCs despite standard provocation, at the Hospital of the University of Pennsylvania between 2022 and 2024. Stimulation was performed via the left VV (20 Hz, up to 25 mA).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The primary outcome was PVC frequency, assessed before, during, and after stimulation. A multilevel mixed-effects Poisson regression was used to compare the rate of PVCs during the procedure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Fifteen patients (mean [SD] age, 60 [17] years; 10 male [71%]) had a mean (SD) preprocedure PVC burden of 16.3% (8.6%) (median [IQR], 17.0% [11.5%-21.5%]), and 7 of 15 had undergone at least 1 prior unsuccessful ablation. Provocation of PVCs was attempted with isoproterenol, atrial and ventricular burst pacing, and minimal sedation in all patients before VV stimulation. Throughout the 10-minute period before VV stimulation, patients had a mean (SD) of 1.3 (1.4) PVCs (median [IQR], 1.0 [0.0-2.5] PVCs). During VV stimulation, PVCs were noted in all patients (mean [SD], 8.2 [5.7] PVCs per minute; median [IQR], 6.0 [4.5-13.0] PVCs per minute). In the 10-minute period after VV stimulation, patients had a mean (SD) of 5.1 (6.6) PVCs per minute (median [IQR], 3.0 [0.5-6.5] PVCs per minute). After VV stimulation, ablation was guided by activation mapping in 7 patients and by pace mapping alone in the remaining patients. Postablation monitoring demonstrated a mean (SD) 1.3% (2.3%) burden of PVCs (median [IQR], 0.0% [0.0%-2.5%]), with 9 of 15 patients having less than 1% burden of PVCs. There were no adverse events related to VV stimulation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: These findings suggest that intravascular sympathetic stimulation via the VV can be used to safely provoke PVCs during catheter ablation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714902/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39714902</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.4447>10.1001/jamacardio.2024.4447</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714902</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Timothy M Markman</dc:creator>
<dc:creator>Cory M Tschabrunn</dc:creator>
<dc:creator>David Callans</dc:creator>
<dc:creator>Francis E Marchlinski</dc:creator>
<dc:creator>Saman Nazarian</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Intravascular Sympathetic Stimulation to Facilitate Catheter Ablation of Premature Ventricular Complexes</dc:title>
<dc:identifier>pmid:39714902</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.4447</dc:identifier>
</item>
<item>
<title>Representation of Women Among Cardiology Grand Rounds Speakers in the United States</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714874/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: Women compose about 1 in 5 cardiology GR speakers with modest growth in representation over time but remain underrepresented as GR speakers for procedural cardiology and basic/translational science topics.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Dec 23. doi: 10.1001/jamacardio.2024.4255. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Women are underrepresented in leadership positions in cardiology. Institutional grand rounds (GR) are platforms through which faculty can gain professional exposure and access to career development opportunities. The gender diversity of invited cardiology GR speakers has not been investigated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To examine the representation of women among cardiology GR speakers in the United States.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study reviewed all 626 internal medicine residency training program websites in the American Medical Association's FRIEDA directory to identify publicly available records of cardiology GR. Grand rounds from September 1997 through December 2022 were included; GR with more than 1 speaker and trainee-led case conferences were excluded.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURES: Grand rounds speaker gender.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Data on GR topic focus, speaker gender, and academic rank were collected.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 3806 GR lectures at 42 institutions were included; 799 (21%) were delivered by women and 3007 (79%) by men. The proportion of women GR speakers increased by 1% per year and increased for each topic over time with the exception of electrophysiology and basic/translational science. Women were most likely to speak on women's cardiovascular health (80 lectures [10.0%] vs 17 [0.6%] for men; P &lt; .001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: Women compose about 1 in 5 cardiology GR speakers with modest growth in representation over time but remain underrepresented as GR speakers for procedural cardiology and basic/translational science topics.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714874/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39714874</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.4255>10.1001/jamacardio.2024.4255</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714874</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Ersilia M DeFilippis</dc:creator>
<dc:creator>Supriya Muppala</dc:creator>
<dc:creator>Gurleen Kaur</dc:creator>
<dc:creator>Jessica H Huston</dc:creator>
<dc:creator>Robert A Harrington</dc:creator>
<dc:creator>Quinn Capers</dc:creator>
<dc:creator>Pamela S Douglas</dc:creator>
<dc:creator>Nadim Mahmud</dc:creator>
<dc:creator>Nosheen Reza</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Representation of Women Among Cardiology Grand Rounds Speakers in the United States</dc:title>
<dc:identifier>pmid:39714874</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.4255</dc:identifier>
</item>
<item>
<title>Plugging the gap: vascular access closure after transfemoral transcatheter aortic valve implantation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714781/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23:ehae876. doi: 10.1093/eurheartj/ehae876. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714781/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39714781</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae876>10.1093/eurheartj/ehae876</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714781</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Daniel T Y Ang</dc:creator>
<dc:creator>M Mitchell Lindsay</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Plugging the gap: vascular access closure after transfemoral transcatheter aortic valve implantation</dc:title>
<dc:identifier>pmid:39714781</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae876</dc:identifier>
</item>
<item>
<title>The hypothesis: a new article type and platform for iconoclasts in medicine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714777/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23:ehae770. doi: 10.1093/eurheartj/ehae770. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714777/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39714777</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae770>10.1093/eurheartj/ehae770</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714777</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Milton Packer</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The hypothesis: a new article type and platform for iconoclasts in medicine</dc:title>
<dc:identifier>pmid:39714777</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae770</dc:identifier>
</item>
<item>
<title>Whether women undergoing assisted reproductive technologies have an increased risk of cardiovascular disease remains an unanswered question</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714774/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23:ehae910. doi: 10.1093/eurheartj/ehae910. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714774/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39714774</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae910>10.1093/eurheartj/ehae910</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714774</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Maria Christine Magnus</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Whether women undergoing assisted reproductive technologies have an increased risk of cardiovascular disease remains an unanswered question</dc:title>
<dc:identifier>pmid:39714774</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae910</dc:identifier>
</item>
<item>
<title>Cardiovascular safety of assisted reproductive technology: a meta-analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39710934/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Assisted reproductive technology use does not appear to be significantly associated with an increased long-term risk of cardiovascular diseases in women. While these findings suggest the cardiovascular safety of fertility treatments, further research is warranted.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23:ehae886. doi: 10.1093/eurheartj/ehae886. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: The increasing use of assisted reproductive technology (ART) has raised concerns regarding its long-term cardiovascular safety due to potential hormonal imbalances and pro-thrombotic states. This study aimed to assess the long-term cardiovascular risk associated with fertility treatments in women.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Following PRISMA guidelines, a systematic review and meta-analysis was conducted in MEDLINE (via PubMed) from inception to January 2024. Randomized, cohort, or case-control studies were included if fulfilling the following criteria: the association between ART and the subsequent cardiovascular outcome was reported and adjusted for confounding factors (at least age); the presence of a control group; and minimum 1-year follow-up. Effect size (ES) estimates of the association between fertility therapy and subsequent cardiovascular disease were pooled using the DerSimonian and Laird random-effects model. Heterogeneity was assessed with the I2 index. This study is registered on PROSPERO (CRD42024505605).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of the 7298 articles screened, 10 studies were included, encompassing 500 664 women undergoing ART and 36 395 240 controls. The analysis found no significant increase in the long-term risk of major adverse cardiovascular events [ES 1.04, 95% confidence interval (CI) 0.88-1.23, I2 87.61%, P = .63], coronary heart disease (ES 0.88, 95% CI 0.71-1.10, I2 24.36%, P = .26), stroke (ES 1.21, 95% CI 0.92-1.59, I2 70.40%, P = .17), venous thromboembolism (ES 0.95, 95% CI 0.70-1.28, I2 49.13%, P = .73), hypertension (ES 1.08, 95% CI 0.88-1.32, I2 94.63%, P = .46), or diabetes (ES 1.03, 95% CI 0.86-1.22, I2 78.44%, P = .77). Assisted reproductive technology was associated with a lower risk of heart failure (ES 0.75, 95% CI 0.60-0.94, I2 0.00%, P = .01).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Assisted reproductive technology use does not appear to be significantly associated with an increased long-term risk of cardiovascular diseases in women. While these findings suggest the cardiovascular safety of fertility treatments, further research is warranted.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39710934/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39710934</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae886>10.1093/eurheartj/ehae886</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39710934</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Carlo Andrea Pivato</dc:creator>
<dc:creator>Annalisa Inversetti</dc:creator>
<dc:creator>Gianluigi Condorelli</dc:creator>
<dc:creator>Alaide Chieffo</dc:creator>
<dc:creator>Paolo Emanuele Levi-Setti</dc:creator>
<dc:creator>Alessia Chiara Latini</dc:creator>
<dc:creator>Andrea Busnelli</dc:creator>
<dc:creator>Martina Messa</dc:creator>
<dc:creator>Martina Cristodoro</dc:creator>
<dc:creator>Renato Maria Bragato</dc:creator>
<dc:creator>Marco Francone</dc:creator>
<dc:creator>Luisa Zuccolo</dc:creator>
<dc:creator>Francesca Ieva</dc:creator>
<dc:creator>Emanuele Di Angelantonio</dc:creator>
<dc:creator>Giulio Stefanini</dc:creator>
<dc:creator>Nicoletta Di Simone</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardiovascular safety of assisted reproductive technology: a meta-analysis</dc:title>
<dc:identifier>pmid:39710934</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae886</dc:identifier>
</item>
<item>
<title>Sex-specific risk factors: new light shed on gestational diabetes and obesity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39709997/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250101051114&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23;45(48):5105-5108. doi: 10.1093/eurheartj/ehae837.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39709997/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250101051114&v=2.18.0.post9+e462414">39709997</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae837>10.1093/eurheartj/ehae837</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39709997</guid>
<pubDate>Sun, 22 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-12-22</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Sex-specific risk factors: new light shed on gestational diabetes and obesity</dc:title>
<dc:identifier>pmid:39709997</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae837</dc:identifier>
</item>





























</channel>
</rss>